Compare Cadila Healthcare with J.B.Chemicals - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CADILA HEALTHCARE vs J.B.CHEMICALS - Comparison Results

CADILA HEALTHCARE     Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

J.B.CHEMICALS 
   Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CADILA HEALTHCARE J.B.CHEMICALS CADILA HEALTHCARE/
J.B.CHEMICALS
 
P/E (TTM) x 33.8 44.8 75.6% View Chart
P/BV x 5.9 8.3 71.2% View Chart
Dividend Yield % 0.6 0.1 412.0%  

Financials

 CADILA HEALTHCARE   J.B.CHEMICALS
EQUITY SHARE DATA
    CADILA HEALTHCARE
Mar-20
J.B.CHEMICALS
Mar-18
CADILA HEALTHCARE/
J.B.CHEMICALS
5-Yr Chart
Click to enlarge
High Rs352363 97.0%   
Low Rs207255 81.0%   
Sales per share (Unadj.) Rs139.2169.1 82.3%  
Earnings per share (Unadj.) Rs11.816.6 70.9%  
Cash flow per share (Unadj.) Rs18.623.4 79.3%  
Dividends per share (Unadj.) Rs3.502.00 175.0%  
Dividend yield (eoy) %1.30.6 193.6%  
Book value per share (Unadj.) Rs101.4172.5 58.8%  
Shares outstanding (eoy) m1,023.7483.57 1,225.0%   
Bonus/Rights/Conversions -BB-  
Price / Sales ratio x2.01.8 109.8%   
Avg P/E ratio x23.718.6 127.6%  
P/CF ratio (eoy) x15.013.2 114.0%  
Price / Book Value ratio x2.81.8 153.9%  
Dividend payout %29.812.0 246.9%   
Avg Mkt Cap Rs m286,03325,827 1,107.5%   
No. of employees `00013.43.8 355.4%   
Total wages/salary Rs m24,1452,511 961.6%   
Avg. sales/employee Rs Th10,632.73,747.4 283.7%   
Avg. wages/employee Rs Th1,801.2665.7 270.6%   
Avg. net profit/employee Rs Th898.5367.8 244.3%   
INCOME DATA
Net Sales Rs m142,53114,135 1,008.3%  
Other income Rs m1,139366 311.4%   
Total revenues Rs m143,67014,501 990.8%   
Gross profit Rs m24,1982,178 1,110.9%  
Depreciation Rs m6,965570 1,222.6%   
Interest Rs m3,41835 9,793.7%   
Profit before tax Rs m14,9541,940 771.0%   
Minority Interest Rs m2880-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3,198552 579.0%   
Profit after tax Rs m12,0441,387 868.2%  
Gross profit margin %17.015.4 110.2%  
Effective tax rate %21.428.5 75.1%   
Net profit margin %8.59.8 86.1%  
BALANCE SHEET DATA
Current assets Rs m87,15410,470 832.4%   
Current liabilities Rs m82,6942,749 3,008.1%   
Net working cap to sales %3.154.6 5.7%  
Current ratio x1.13.8 27.7%  
Inventory Days Days7155 129.4%  
Debtors Days Days9478 120.8%  
Net fixed assets Rs m133,2365,811 2,292.8%   
Share capital Rs m1,024167 612.8%   
"Free" reserves Rs m102,73314,248 721.0%   
Net worth Rs m103,75714,416 719.8%   
Long term debt Rs m32,1460-   
Total assets Rs m236,86617,649 1,342.1%  
Interest coverage x5.456.6 9.5%   
Debt to equity ratio x0.30-  
Sales to assets ratio x0.60.8 75.1%   
Return on assets %6.58.1 81.0%  
Return on equity %11.69.6 120.6%  
Return on capital %13.713.7 100.2%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m52,7526,164 855.8%   
Fx outflow Rs m14,5041,334 1,086.9%   
Net fx Rs m38,2484,829 792.0%   
CASH FLOW
From Operations Rs m25,0541,231 2,036.1%  
From Investments Rs m-10,123-208 4,864.5%  
From Financial Activity Rs m-10,942-595 1,838.4%  
Net Cashflow Rs m3,989427 934.0%  

Share Holding

Indian Promoters % 74.8 55.4 135.0%  
Foreign collaborators % 0.0 0.3 -  
Indian inst/Mut Fund % 8.3 3.4 244.8%  
FIIs % 5.9 3.9 151.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 11.0 37.0 29.7%  
Shareholders   44,069 30,437 144.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CADILA HEALTHCARE With:   STERLING BIOTECH  SANOFI INDIA  ALEMBIC PHARMA  ORCHID PHARMA  NOVARTIS  

Compare CADILA HEALTHCARE With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

RBI's Relief Measures Amid Covid, 5G Trials by Mobile Operators, and Buzzing Stocks Today(Pre-Open)

Indian share markets witnessed positive trading activity throughout the day yesterday and ended higher.

Related Views on News

CADILA HEALTHCARE Announces Quarterly Results (3QFY21); Net Profit Up 40.6% (Quarterly Result Update)

Feb 10, 2021 | Updated on Feb 10, 2021

For the quarter ended December 2020, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (up 40.6% YoY). Sales on the other hand came in at Rs 38 bn (up 4.3% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE 2019-20 Annual Report Analysis (Annual Result Update)

Oct 26, 2020 | Updated on Oct 26, 2020

Here's an analysis of the annual report of CADILA HEALTHCARE for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of CADILA HEALTHCARE. Also includes updates on the valuation of CADILA HEALTHCARE.

CADILA HEALTHCARE Announces Quarterly Results (1QFY21); Net Profit Up 49.3% (Quarterly Result Update)

Aug 21, 2020 | Updated on Aug 21, 2020

For the quarter ended June 2020, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (up 49.3% YoY). Sales on the other hand came in at Rs 36 bn (up 4.1% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

J.B.CHEMICALS Announces Quarterly Results (3QFY20); Net Profit Up 34.1% (Quarterly Result Update)

Feb 6, 2020 | Updated on Feb 6, 2020

For the quarter ended December 2019, J.B.CHEMICALS has posted a net profit of Rs 622 m (up 34.1% YoY). Sales on the other hand came in at Rs 4 bn (up 9.3% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (2QFY20); Net Profit Down 79.3% (Quarterly Result Update)

Nov 15, 2019 | Updated on Nov 15, 2019

For the quarter ended September 2019, CADILA HEALTHCARE has posted a net profit of Rs 829 m (down 79.3% YoY). Sales on the other hand came in at Rs 34 bn (up 13.7% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

More Views on News

Most Popular

Power Grid's InvIT IPO: Key Points to Consider(Company Info)

Apr 23, 2021

In this article, we discuss the key reasons why the stock of Power Grid was in focus today.

Time to Buy Smallcaps?(Fast Profits Daily)

Apr 30, 2021

In this video, I'll show you why I favour smallcaps over the Nifty.

The Next Smallcap Winners(Profit Hunter)

Apr 30, 2021

Price is the only due diligence one might require to buy this business.

This Fund Manager Has Taken the World by Storm. Will You Invest With Her?(Profit Hunter)

Apr 26, 2021

Should you invest with this Rockstar fund manager who has outperformed in a big way?

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

CADILA HEALTHCARE SHARE PRICE


May 5, 2021 (Close)

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE 5-YR ANALYSIS

COMPARE CADILA HEALTHCARE WITH

MARKET STATS